ASCO GI 2022 Conference Coverage


 

ASCO GI 2022 Updates on IMbrave150 Trial: Exploratory Efficacy & Safety in Unresectable HCC Treated With Atezo Beyond Radiological Progression Until the Loss of Clinical Benefit

93 views
January 26, 2022
0 Comments
Login to view comments. Click here to Login